SOU, Alm.del - 2011-12 - Bilag 408: Henvendelse af 4/9-12 fra Reckitt Benckiser Pharmaceuticals vedr. nordisk konference om behandling af heroinafhængighed og mulighederne for at forbedre heroinmisbrugernes levestandard og udsigter

Youare invitedTime to actOpiate dependence is a brain-related disorder that can be effectively treated with significant benefits for patients and society. However,the Nordic countries have made insufficient commitment to offer effective treatment for opiate dependence for those who need. Why?The 6th Nordic Opioid Addiction Treatment Conference will focus on challenges in each of the Nordic countries and suggest actions on how toimprove treatment and the patients conditions in a broader sense. Based on a Delphi Study, a group of Nordic experts have discussed the urgencyfor improvement in a field that still leaves much to be desired.The next step is to broaden the discussion in a forum of healthcare professionals, politicians and others, hopefully makingthe visions for the desired state of treatment vigorous and successful. As a professional and an expert within this field,we’d like to invite you to join the conference and participate in the discussion and contribute to a Nordic consensus.Yours sincerelyJohan Kakko, MD, Ph.D.Chairman of The Delphi Panel

For morE iNFormaTioN:Please confirm your participation in the conference by visitingthe websitewww.6thNordic.com,using your personal passwordbelow. On the webpage you can read more about the program,participants, book flights and much more.YOUR PASSWORD:rethinkThe 6th Nordic OpioidAddiction Treatment ConferenceVENUE:Tivoli HotelCopenhagen, Denmark